CHINARES PHARMA(03320): China Resources Boya Bio-pharmaceutical Group's net profit for the first three quarters was 343 million yuan, a decrease of 16.8% year-on-year.

20:03 27/10/2025

China Resources Pharmaceutical (03320) announced that China Resources Boao Bio-Tech achieved... as of the nine months ended September 30, 2025.

CHINARES PHARMA (03320) announced that China Resources Boya Bio-pharmaceutical Group achieved a total operating income of 1.474 billion yuan in the nine months ending September 30, 2025, an increase of 18.4% year-on-year; net profit was 343 million yuan, a decrease of 16.8% year-on-year.

China Longyuan Power Group Corporation (00916) has successfully issued 2.5 billion yuan of ultra-short-term financing bonds.

Zhejiang Shibao (01057) released its performance for the first three quarters, with a net profit attributable to the parent company of 150 million yuan, an increase of 33.66% year-on-year.

Horse Tea (06980): Hong Kong public offering was oversubscribed by 2680.04 times, with an offer price of HK$50 per share.

China Longyuan Power Group Corporation (00916) has successfully issued 2.5 billion yuan of ultra-short-term financing bonds.

Zhejiang Shibao (01057) released its performance for the first three quarters, with a net profit attributable to the parent company of 150 million yuan, an increase of 33.66% year-on-year.

Horse Tea (06980): Hong Kong public offering was oversubscribed by 2680.04 times, with an offer price of HK$50 per share.